Filing Details
- Accession Number:
- 0001447362-20-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-04 16:46:19
- Reporting Period:
- 2020-04-30
- Accepted Time:
- 2020-05-04 16:46:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1447362 | Castle Biosciences Inc | CSTL | Services-Medical Laboratories (8071) | 770701744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588970 | H Bonnie Anderson | C/O Castle Biosciences 820 S. Friendswood Drive, Suite 201 Friendswood TX 77546 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-30 | 2,538 | $30.09 | 35,185 | No | 4 | S | Indirect | By trust |
Common Stock | Disposition | 2020-04-30 | 462 | $31.10 | 34,723 | No | 4 | S | Indirect | By trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By trust |
No | 4 | S | Indirect | By trust |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2020.
- This transaction was executed in multiple trades at prices ranging from $29.59 to $30.38, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Held by the Bonnie H. Anderson Living Trust, or the Anderson Trust. The Reporting Person is the trustee of the Anderson Trust.
- This transaction was executed in multiple trades at prices ranging from $30.73 to $31.52, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.